Bortezomib

Bortezomib

Product Details:

  • Smell Odorless
  • Heavy Metal (%) Complies with industry standards (less than 10 ppm)
  • Solubility Soluble in DMSO and methanol
  • Molecular Weight 384.24 g/mol
  • Poisonous YES
  • Loss on Drying Not more than 1.0%
  • Melting Point 122-124C
  • Click to View more
X

Bortezomib Product Specifications

  • C19H25BN4O4
  • 2 years under recommended storage conditions
  • Micronized
  • Bortezomib
  • C19H25BN4O4
  • YES
  • 122-124C
  • Not more than 1.0%
  • Proteasome Inhibitor
  • 384.24 g/mol
  • 179324-69-7
  • Solid
  • Complies with industry standards (less than 10 ppm)
  • Soluble in DMSO and methanol
  • Odorless
  • White to off-white powder
  • None available
  • Store at -20C protected from light and moisture.
  • Neutral
  • 99%
  • N-(2-pyrazinylcarbonyl)-L-phenylalanine-L-leucine boronic acid
  • Used in the treatment of certain types of cancer including multiple myeloma and mantle cell lymphoma.
  • 29337900
  • White to off-white
  • Pharmaceutical Grade

Product Description



Bortezomib, a pharmaceutical-grade proteasome inhibitor, is renowned for its efficacy in treating various cancers such as multiple myeloma and mantle cell lymphoma. As a solid compound, it is characterized by its odorless nature and white to off-white appearance. With a purity level of 99%, it meets industry standards, ensuring consistent results in medical applications. The particle size is micronized for precise formulation, with heavy metal content strictly controlled to less than 10 ppm. Bortezomib has a neutral pH, and its solubility in DMSO and methanol facilitates flexible handling in research and medical settings. Its molecular weight is 384.24 g/mol, and its melting point ranges between 122-124C. For optimal preservation, it should be stored at -20C, protected from light and moisture, maintaining its shelf life of up to 2 years. It complies with pharmaceutical industry standards for purity and stability, rendering it reliable in critical applications.

FAQs of Bortezomib:


Q: What is the primary use of Bortezomib?

A: Bortezomib is primarily used in the treatment of specific cancers, such as multiple myeloma and mantle cell lymphoma.

Q: How should Bortezomib be stored?

A: Bortezomib should be stored at -20C, away from light and moisture, to maintain its stability and shelf life.

Q: What is the molecular formula of Bortezomib?

A: The molecular formula of Bortezomib is C19H25BN4O4.

Q: Is Bortezomib soluble?

A: Yes, Bortezomib is soluble in DMSO and methanol.

Q: Does Bortezomib comply with heavy metal standards?

A: Yes, Bortezomib complies with industry standards, with heavy metal content being less than 10 ppm.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Active Pharmaceutical Ingredient' category



Back to top